Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
mHealth stands for mobile health and is the sub-segment of eHealth that deals with the medicinal practice in favor of public health care, supported by mobile devices. The term mHealth is used to refer the use of mobile communication devices such as mobile phones, electronic tablets, PDAs and also comprises of wearable devices such as a smart watch for data collection and information about health care services.
The global mHealth market is estimated to account for US$ 23.4 Bn in terms of value in 2020 and is expected to reach US$ 107.6 Bn by the end of 2027.
Global mHealth Market: Drivers
Increasing adoption of smartphones is expected to propel growth of the global mHealth market over the forecast period. For instance, according to Pew Research Center, as of February 2019, 81% of U.S. adults used smartphones compared to 77% in October 2018.
Moreover, increasing prevalence of chronic diseases is also expected to aid in growth of the market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
General healthcare and fitness held dominant position in the global mHealth market in 2019, accounting for 36.6% share in terms of value, followed by Health data and record access and Healthcare management, respectively.
Figure 1. Global mHealth Market Share (%), by Value, by Application, 2019
Global mHealth Market: Restraints
Low adoption of internet in some emerging economies is expected to hinder growth of the global mHealth market. For instance, according to Pew Research Center (October 2019), Sub-Saharan Africa has a lower level of internet use than any other geographic region, ranging from a high of 59% in South Africa to a low of 25% in Tanzania. hibits the growth of the mHealth market.
Moreover, resistance to change in general, existence of unreliable technologies, non-uniformity of technological availability, lack of end-user education, and many other issues are also expected to limit adoption of mHealth.
mHealth Market Report Coverage
||Market Size in 2019:
||US$ 16.7 Bn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 107.6 Bn
- North America: U.S., Canada
- Latin America: Brazil, Argentina, Mexico, Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
- Middle East: GCC Countries, Israel, Rest of Middle East
- Africa: South Africa, North Africa, Central Africa
- By Service:
- Solutions for patients: Wellness, Prevention service, Monitoring service, Diagnostic service, Treatment service, Information and reference.
- Healthcare system strengthening: Emergency response, Health care practitioner support, Healthcare surveillance.
- By Application: General healthcare and fitness, Medication information, Remote monitoring, collaboration and consultancy, Healthcare management, Health data and record access.
- By End User: Public/Private healthcare institutions, Physicians, Healthcare workers, Individuals.
Medtronic Inc., Apple Inc., Sanofi, Mobistante, Inc., AirStrip Technologies, Inc., AliveCor, Inc., LifeWatch AG, Koninklijke Philips N.V, Jawbone, Nike, Inc., Omron Corporation, Johnson and Johnson, Bio Telemetry Inc., Withings, AgaMatrix Inc., iHealth Lab Inc., Elucid Mhealth, Qualcomm, AT&T, Cerner Corporation and Cisco Inc.
- Technological advancement
- Increasing use of mobile applications
|Restraints & Challenges:
- Low adoption of internet in some emerging economies
Global mHealth Market: Opportunities
Increasing penetration of internet is expected to offer lucrative growth opportunities for players in the global mHealth market. For instance, according to China government-backed Market Intelligence & Consulting Institute and reported by China Internet Watch, internet penetration in China reached 61.2 percent in the first half of 2019, with 854 million internet users at the end of June 2019.
Moreover, launch of 5G services is also expected to boost adoption of mHealth. For instance, over 45 operators launched 5G services and more than 40 OEMs are introducing devices in the beginning of 2020.
The global mHealth market was valued at US$ 23.4 Bn in 2019 and is forecast to reach a value of US$ 107.6 Bn by 2027 at a CAGR of 24.4% between 2020 and 2027.
Figure 2. Global mHealth Market Value (US$ Bn), and Y-o-Y Growth (%), 2019-2027
Market Trends/Key Takeaways
Emergence of Covid-19 is expected to propel growth of the global mhealth market. For instance, globally, as of 3:50pm CEST, 22 June 2020, there have been 8,860,331 confirmed cases of COVID-19, including 465,740 deaths, reported to the World Health Organization.
Moreover, launch of new connected device software is also expected to aid in growth of the market. For instance, in May 2019, MedShift launched Version 2 of its connected device software, a new secure cloud computing platform designed to enhance manufacturer visibility, and device ROI.
Global mHealth Market: Competitive Landscape
Major players operating the global mHealth market include, Medtronic Inc., Apple Inc., Sanofi, Mobistante, Inc., AirStrip Technologies, Inc., AliveCor, Inc., LifeWatch AG, Koninklijke Philips N.V, Jawbone, Nike, Inc., Omron Corporation, Johnson and Johnson, Bio Telemetry Inc., Withings, AgaMatrix Inc., iHealth Lab Inc., Elucid Mhealth, Qualcomm, AT&T, Cerner Corporation and Cisco Inc.
Global mHealth Market: Key Developments
Major players in the global mHealth market are focused on launching new products to expand their product portfolio. For instance, in April 2018, Oracle Corporation, a multinational computer tech company, launched its Oracle Health Sciences mHealth connector cloud service designed to aid clinical study teams in remotely collecting data from patient sensors, wearable and apps for use in clinical trials.
Similarly, in September 2019, Elucid Mhealth was awarded the U.S. patents for its Pill Connect system, a patient medication adherence system.